What Is Dihexa? Benefits, Research & Safety

Dihexa was developed at Washington State University by Dr. Joseph Harding and colleagues, researchers who had been studying the cognitive effects of the angiotensin system for decades. The angiotensin system, primarily known for blood pressure regulation, was discovered to have cognitive effects independent of its cardiovascular actions. Angiotensin IV, in particular, was found to enhance memory and learning in animal models. However, angiotensin IV itself is a peptide with poor oral bioavailability and limited brain penetration. The WSU team developed a series of small molecule analogues designed to retain cognitive-enhancing properties while improving drug-like characteristics. Dihexa emerged from this programme as an exceptionally potent compound. Key discoveries included: - Picomolar potency (approximately 7 orders of magnitude more potent than BDNF) - Oral bioavailability - Blood-brain barrier penetration - Ability to reverse cognitive deficits in multiple animal models The compound was patented and licensed for development, with initial interest in Alzheimer's disease and other dementias. However, as of 2026, no human clinical trials have been published, and the compound remains in early research phases.